Risk factors for and management of cognitive dysfunction in multiple sclerosis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Clinical Neurology
Link
http://www.nature.com/articles/nrneurol.2011.61.pdf
Reference159 articles.
1. Hauser, S. L., Oksenberg, J. R., Hauser, S. L. & Oksenberg, J. R. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 52, 61–76 (2006).
2. Charcot, J. M. Lectures on the Diseases of the Nervous System (New Sydenham Society, London, 1877).
3. Rao, S. M., Leo, G. J., Bernardin, L. & Unverzagt, F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 41, 685–691 (1991).
4. [No authors listed] Interferon beta-1b is effective in relapsing–remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group. Neurology 43, 655–661 (1993).
5. Jacobs, L. D. et al. A phase III trial of intramuscular recombinant interferon beta as treatment for exascerbating–remitting multiple sclerosis: design and conduct of study and baseline characteristics of patients. Mult. Scler. 1, 118–135 (1995).
Cited by 306 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Clinical features of sleep apnea syndrome and cognitive impairment in multiple sclerosis;Multiple Sclerosis and Related Disorders;2024-02
2. Isolated cognitive impairment in people with multiple sclerosis: frequency, MRI patterns and its development over time;Journal of Neurology;2024-01-30
3. A screening method for mild cognitive impairment in elderly individuals combining bioimpedance and MMSE;Frontiers in Aging Neuroscience;2024-01-24
4. Comparing the effect of in water vs. land vs. combined land–water training on functional mobility and balance in women with multiple sclerosis: a Burdenko method;Sport Sciences for Health;2024-01-05
5. Beliefs about Medicines and the Level of Intentional Non-Adherence to Treatment among Patients with Multiple Sclerosis Treated with First-Line Drugs;Journal of Clinical Medicine;2023-12-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3